retatrutide to tirzepatide Switching from retatrutide: the complete transition guide Retatrutide vs Tirzepatide: Comprehensive Comparison

[1] [2] As of mid-2025, retatrutide has not received approval from the MHRA or EMA and remains under clinical investigation (ClinicalTrials

Maintenance strategies after discontinuation Researchers who have achieved significant weight loss with retatrutide should have a maintenance strategy in place before discontinuing

These treatments are not routinely available for weight management alone and must meet specific eligibility requirements outlined in NICE guidance

Is waist circumference changing

Importantly, these trials exhibited a high degree of heterogeneity in terms of the types of substances studied, patient characteristics, and treatment protocols, which posed significant challenges to drawing definitive conclusions

Catalog specs are planning figures only